
Dyslipidemia
Learn about the latest trends, discover events and innovations in the changing world of dyslipidemia disease.
Science in Dyslipidemia Disease
Get a 360º view and stay up-to-date on cardiovascular disease with content selected for you

- Dyslipidemia
Cardiovascular diseases (CVDs) are the leading cause of death globally1
According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths1. Of these deaths, 85% were due to myocardial infarction or stroke1.
A CV event is a highly traumatic experience for patients and their families2. It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life3,4.

- Dyslipidemia
- Dyslipidemia
Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

- Dyslipidemia
Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice
.webp/jcr:content/Lipid-lowering-therapy-thumb%20(2).webp)
- Dyslipidemia
- Cardiovascular
Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

- Dyslipidemia
Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources

- Dyslipidemia
- Dyslipidemia
Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

- Dyslipidemia
- Cardiovascular
- Dyslipidemia
Statin/ezetimibe SPC for better adherence to LLT
.webp/jcr:content/3%20(3).webp)
- Dyslipidemia
- Cardiovascular
- Dyslipidemia
Managing Recurrent ASCVD risk of your ACS Patient: A call to Action – GULF Perspective: Part 2

- Dyslipidemia
- Cardiovascular
- Dyslipidemia
Lp(a) and PCSK9 inhibition in nominally controlled LDL-C patients

- Dyslipidemia
- Cardiovascular
- Dyslipidemia
Atherosclerosis: Identifying risks and improving outcomes
.webp/jcr:content/4%20(2).webp)
- Dyslipidemia
- Cardiovascular
- Dyslipidemia
Managing the Recurrent ASCVD Risks of Your ACS Patient: A call to Action – GULF Perspective: Part 3
.webp/jcr:content/2%20(2).webp)
- Dyslipidemia
- Cardiovascular
- Dyslipidemia
Managing the Recurrent ASCVD Risks of Your ACS Patient: Gulf Perspective (Part 1)
Events
Stay up to date and register for the latest events and view webinar recordings.